6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: lapatinib|DRUG: BIBW 2992|DRUG: trastuzumab
Sponsor: Boehringer Ingelheim